A detailed history of Cibc Bancorp Usa Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cibc Bancorp Usa Inc. holds 620,472 shares of BMY stock, worth $29 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
620,472
Holding current value
$29 Million
% of portfolio
0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 21, 2025

SELL
$43.31 - $48.98 $14.7 Million - $16.6 Million
-339,667 Reduced 54.74%
280,805 $12.7 Million
Q3 2025

Nov 12, 2025

BUY
$43.31 - $48.98 $26.9 Million - $30.4 Million
620,472 New
620,472 $28 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.5B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Cibc Bancorp Usa Inc. Portfolio

Follow Cibc Bancorp Usa Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Bancorp Usa Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cibc Bancorp Usa Inc. with notifications on news.